Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Illumina (NASDAQ:ILMN) through any online brokerage.
Other companies in Illumina’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).
Illumina has a consensus price target of $180.52.
The stock price for Illumina (NASDAQ: ILMN) is $273.2356 last updated October 5, 2026 at 7:43 AM EDT.
There are no upcoming dividends for Illumina.
Illumina does not have any upcoming earnings scheduled.
There is no upcoming split for Illumina.
Illumina is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.